MCB raises USD350m in Syndicated Loan from Asia
PORT LOUIS, Republic of Mauritius, Feb. 19, 2025 /PRNewswire/ -- The Mauritius…
Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers
Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers…
NRF 2025: Retail’s Big Show Asia Pacific Unveils Conference Speaker Line-up Featuring Leaders from Top Global and Regional Brands
Participating retail brands include Love, Bonito, Authentic Brands Group, Alfamart, Castlery, Suntory,…
The Solutions Project Celebrates 5th Annual Black Climate Week From Monday, Feb 17 – Sunday, Feb 23
This award-winning campaign raises awareness about the climate & societal benefits of…
Galapagos receives transparency notification and 13D filing from Tang Capital
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV…
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results…
Japan’s Leading Crypto Tax Service, cryptact, Now Available in Canada – Trusted Reports from US$22.50
As Japan's top crypto tax service, trusted by more than 150,000 users…
Anaptys to Announce Top-line Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025
February 11, 2025 17:30 ET | Source: AnaptysBio, Inc. SAN DIEGO, Feb.…
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…
ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051
MELBOURNE, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage…